Roche Partners With Tekmira to Advance RNAi Product Candidates

Tekmira Pharmaceuticals Corporation announced that it has entered into a product development agreement with global healthcare company Roche to advance Roche’s first two RNA interference (RNAi) product candidates into human clinical testing.
Earth Times